Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor - Contacts and Locations

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00055952

Locations


United States, Colorado
	University of Colorado Cancer Center at University of Colorado Health Sciences Center
	Denver, Colorado, United States, 80218

United States, Florida
	Nemours Children's Clinic
	Jacksonville, Florida, United States, 32207

United States, New Jersey
	Cancer Institute of New Jersey
	New Brunswick, New Jersey, United States, 08903

United States, New York
	Memorial Sloan-Kettering Cancer Center
	New York, New York, United States, 10021

United States, Tennessee
	St. Jude Children's Research Hospital
	Memphis, Tennessee, United States, 38105

United States, Texas
	Medical City Dallas Hospital
	Dallas, Texas, United States, 75230
	Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas
	Dallas, Texas, United States, 75390-9063
	University of Texas - MD Anderson Cancer Center
	Houston, Texas, United States, 77030-4009

Canada, Ontario
	Hospital for Sick Children
	Toronto, Ontario, Canada, M5G 1X8

Sponsors and Collaborators

Daiichi Sankyo Inc.

Investigators


Study Chair:	Robert L. DeJager, MD, FACP	Daiichi Sankyo Inc.